Ground Swell Capital LLC Purchases Shares of 541 Axon Enterprise, Inc. (NASDAQ:AXON)

Ground Swell Capital LLC purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 541 shares of the biotechnology company's stock, valued at approximately $322,000.

Other large investors have also recently made changes to their positions in the company. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise during the fourth quarter worth $40,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise in the 4th quarter valued at $45,000. Stonebridge Financial Group LLC acquired a new position in Axon Enterprise during the 4th quarter worth about $53,000. GPS Wealth Strategies Group LLC boosted its holdings in Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after acquiring an additional 40 shares during the period. Finally, Berbice Capital Management LLC acquired a new position in Axon Enterprise in the 4th quarter valued at about $59,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $684.59 on Friday. The stock's 50-day simple moving average is $564.50 and its 200-day simple moving average is $583.86. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market capitalization of $53.29 billion, a PE ratio of 176.90, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. During the same quarter in the prior year, the business posted $1.15 EPS. The company's revenue for the quarter was up 31.3% on a year-over-year basis. As a group, equities research analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently commented on AXON shares. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Barclays lifted their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday. Finally, The Goldman Sachs Group upped their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $640.91.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.